CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation

International Immunology

Volumn 16, Issue 7, 2004, Pages 947-959

  Takeshita, Keisuke ^a   Yamasaki, Tsugiko ^a   Nagao, Koichi ^a   Sugimoto, Hiromi ^a   Shichijo, Michitaka ^a   Gantner, Florian ^a   Bacon, Kevin B ^a  

^a BAYER YAKUHIN LTD   (Japan)

Author keywords

Chemokines; Hypersensitivity; Inflammation; Leukocytes; Prostanoids; Skin

Indexed keywords

3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; CHEMOATTRACTANT; CHEMOKINE; DEXAMETHASONE; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RAMATROBAN; RIDOGREL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; CONTACT ALLERGY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EOSINOPHIL; FEMALE; HUMAN; LEUKOCYTE; LYMPHOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SKIN INFLAMMATION; TH2 CELL;

ANIMALS; CARBAZOLES; CHEMOKINES; CHEMOKINES, CXC; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, ATOPIC; EOSINOPHILS; FEMALE; INFLAMMATION; LEUKOTRIENE B4; MICE; MICE, INBRED BALB C; NEUTROPHIL ACTIVATION; NEUTROPHILS; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION; SULFONAMIDES; TH2 CELLS;

EID: 3242722422     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh096     Document Type: Article

References (44)

1. Lewis, R. A. and Austen, K. F. 1981. Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds. Nature 293:103.
2. Murray, J. J., Tonnel, A. B., Brash, A. R., Roberts, L. J. II, Gosset, P., Workman, R., Capron, A. and Oates, J. A. 1985. Prostaglandin D2 is released during acute allergic bronchospasm in man. Trans. Assoc. Am. Physicians 98:275.
3. Murray, J. J., Tonnel, A. B., Brash, A. R., Roberts, L. J. II, Gosset, P., Workman, R., Capron, A. and Oates, J. A. 1986. Release of prostaglandin D2 into human airways during acute antigen challenge. N. Engl. J. Med. 315:800.
4. Wenzel, S. E., Westcott, J. Y. and Larsen, G. L. 1991. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. J. Allergy Clin. Immunol. 87:540.
5. Nagata, K., Hirai, H., Tanaka, K., Ogawa, K., Aso, T., Sugamura, K., Nakamura, M. and Takano, S. 1999. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett. 459:195.
6. Monneret, G., Gravel, S., Diamond, M., Rokach, J. and Powell, W. S. 2001. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98:1942.
7. Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S. et al. 2001. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193:255.
8. Sugimoto, H., Shichijo, M., Iino, T., Manabe, Y., Watanabe, A., Shimazaki, M., Gantner, F. and Bacon, K. B. 2003. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J. Pharmacol. Exp. Ther. 305:347.
9. Boie, Y., Sawyer, N., Slipetz, D. M., Metters, K. M. and Abramovitz, M. 1995. Molecular cloning and characterization of the human prostanoid DP receptor. J. Biol. Chem. 270:18910.
10. Nagata, K., Tanaka, K., Ogawa, K., Kemmotsu, K., Imai, T., Yoshie, O., Abe, H., Tada, K., Nakamura, M., Sugamura, K. et al. 1999. Selective expression of a novel surface molecule by human Th2 cells in vivo. J. Immunol. 162:1278.
11. Abe, H., Takeshita, T., Nagata, K., Arita, T., Endo, Y., Fujita, T., Takayama, H., Kubo, M. and Sugamura, K. 1999. Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family. Gene 227:71.
12. Seuter, F., Perzborn, E., Rosentreter, U., Boshagen, H. and Fiedler, V. B. 1989. Inhibition of platelet aggregation in vitro and ex vivo by the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido -1,2,3,4-tetrahydro-9-carbazolepropanoic acid. Arzneimittelforschung 39:1525.
13. Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C. H., Sengchanthalangsy, L. L., Ghosh, G. and Glass, C. K. 2000. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl Acad. Sci. USA 97:4844.
14. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M. and Evans, R. M. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803.
15. 12,14-PGJ2: endogenous PPARγ ligand or minor eicosanoid degradation product. J. Clin. Invest. 112:828.
16. Matsumura, H., Nakajima, T., Osaka, T., Satoh, S., Kawase, K., Kubo, E., Kantha, S. S., Kasahara, K. and Hayaishi, O. 1994. Prostaglandin D2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain. Proc. Natl Acad. Sci. USA 91: 11998.
17. Gervais, F. G., Cruz, R. P., Chateauneuf, A., Gale, S., Sawyer, N., Nantel, F., Metters, K. M. and O'Neill G, P. 2001. Selective modulation of chemokinesis, degranulation and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J. Allergy Clin. Immunol. 108:982.
18. Wright, D. H., Nantel, F., Metters, K. M. and Ford-Hutchinson, A. W. 1999. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. Eur. J. Pharmacol. 377:101.
19. Woodward, D. F., Spada, C. S., Hawley, S. B., Williams, L. S., Protzman, C. E. and Nieves, A. L. 1993. Further studies on ocular responses to DP receptor stimulation. Eur. J. Pharmacol. 230:327.
20. Sawyer, N., Cauchon, E., Chateauneuf, A., Cruz, R. P., Nicholson, D. W., Metters, K. M., O'Neill, G. P. and Gervais, F. G. 2002. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br. J. Pharmacol. 137:1163.
21. Hata, A. N., Zent, R., Breyer, M. D. and Breyer, R. M. 2003. Expression and molecular pharmacology of the mouse CRTH2 receptor. J. Pharmacol. Exp. Ther. 306:463.
22. Cosmi, L., Annunziato, F., Galli, G., Manetti, R., Maggi, E. and Romagnani, S. 2001. CRTH2: marker for the detection of human Th2 and Tc2 cells. Adv. Exp. Med. Biol. 495:25.
23. Iwasaki, M., Nagata, K., Takano, S., Takahashi, K., Ishii, N. and Ikezawa, Z. 2002. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J. Invest. Dermatol. 119:609.
24. Cosmi, L., Annunziato, F., Galli, M. I. G., Maggi, R. M. E., Nagata, K. and Romagnani, S. 2000. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur. J. Immunol. 30:2972.
25. Gosset, P., Bureau, F., Angeli, V., Pichavant, M., Faveeuw, C., Tonnel, A. B. and Trottein, F. 2003. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J. Immunol. 170:4943.
26. Shichijo, M., Sugimoto, H., Nagao, K., Inbe, H., Encinas, J., Takeshita, K., Bacon, K. B. and Gantner, F. 2003. Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats. J. Pharmacol. Exp. Therap. 307:518.
27. Macatonia, S. E., Edwards, A. J. and Knight, S. C. 1986. Dendritic cells and the intiation of contact sensitivity to fluorescine isothiocyanate. Immunology 59:509.
28. Dearman, R. J. and Kimber, I. 2000. Role of CD4+ T helper 2-type cells in cutaneous inflammatory responses induced by fluorescine isothiocyanate. Immunology 101:442.
29. Ott, N. L., Gleich, G. J., Peterson, E. A., Fujisawa, T., Sur, S. and Leiferman, K. M. 1994. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. J. All. Clin. Immunol. 94:120.
30. Hart, P. H. 2001. Regulation of the inflammatory response in asthma by mast cell products. Immunol. Cell Biol. 79:149.
31. Palmblad, J., Malmsten, C. L., Uden, A. M., Radmark, O., Engstedt, L. and Samuelsson, B. 1981. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood 58:658.
32. Bacon, K. B., Camp, R. D. R., Cunningham, F. M. and Woollard, P. M. 1988, Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid. Br. J. Pharmacol. 95:966.
33. Bozic, C. R., Gerard, N. P., von Uexkull-Guldenbrand, C., Kolakowski, L. F., Conklyn, M. J., Breslow, R., Showell, H. J. and Gerard, C. 1994. The murine interleukin 8 type B receptor homolog and its ligands. Expression and biological characterization. J. Biol. Chem. 269:29355.
34. Yokoseki, H., Wu, M.-H., Sumi, K., Igawa, K., Miyazaki, Y., Katayama, I., Takeda, K., Akira, S. and Nishioka, K. 2003. Th2 cytokines, IgE and mast cells play a crucial role in the induction of paraphenylenediamine-induced contact hypersensitivity in mice. Clin. Exp. Immunol. 132:385.
35. Kiehl, P., Falkenberg, K., Vogelbruch, M. and Kapp, A. 2001. Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br. J. Dermatol. 145:720.
36. Hammad, H., Jan der Heer, H., Soullie, T., Hoogsteden, H. C., Trottein, F. and Lambrecht, B. N. 2003. Prostaglandin D2 inhibits airway dendritic cell mirgation and function in steady state conditions by selective activation of the D prostanoid receptor 1. J. Immunol. 171:3936.
37. Tanaka, K., Roberts, M. H., Yamamoto, N., Sugiura, H., Uehara, M., Mao, X.-O., Shirakawa, T. and Hopkin, J. M. 2002. Genetic variants of the receptors for thromboxane A2 and IL-4 in atopic dermatitis. Biochem. Biophys. Res. Commun. 292:776.
38. Charlesworth, E. N., Kagey-Sabotka, A., Norman, P. S., Lichtenstein, L. M. and Sampson, H. A. 1993. Cutaneous late-phase response in food allergic children and adolescents with atopic dermatitis. Clin. Exp. All. 23:391.
39. Barr, R. M., Koro, O., Francis, D. M., Black, A. K., Numata, T. and Greaves, M. W. 1988. The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions. Br. J. Pharmacol. 94:773.
40. Iwasaki, M., Nagata, K., Takano, S., Takahashi, K., Ishii, N. and Ikezawa, Z. 2002. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J. Invest. Dermatol. 119:609.
41. Chari, S., Clark-Loeser, L., Shupack, J. and Washenik, M. 2001. A role for leukotriene antagonists in atopic dermatitis? Am. J. Clin. Dermatol. 2:1.
42. Dilulio, N.A., Engeman, T., Armstrong, D., Tannenbaum, C., Hamilton, T. A. and Fairchild, R. L. 1999. Groα-mediated recruitment of neutrophils is required for elicitation of contact hypersensitivity. Eur. J. Immunol. 29:3485.
43. Bacon, K. B., Westick, J. and Camp, R. D. R. 1989. Potent and specific inhibition of IL-8, IL-1 alpha and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists. Biochem. Biophys. Res. Commun. 165:349.
44. Tager, A. M., Bromley, S. K., Medoff, B. D., Islam, S. A., Bercury, S. D., Friedrich, E. B., Carafone, A. D., Gerszten, R. E. and Luster, A. D. 2003. Leukotriene B4 receptor BILT1 mediates early effector T cell recruitment. Nat. Immunol. 4:982.